ACHIEVE LIFE SCIENCES, INC. Logo

ACHIEVE LIFE SCIENCES, INC.

A late-stage pharmaceutical company developing a treatment for nicotine dependence.

ACHV | US

Overview

Corporate Details

ISIN(s):
US0044685008
LEI:
Country:
United States of America
Address:
22722 29TH DR. SE, 98021 SEATTLE

Description

Achieve Life Sciences, Inc. is a late-stage specialty pharmaceutical company dedicated to addressing the global nicotine dependence epidemic. The company's primary focus is the development and commercialization of its lead product candidate, cytisinicline, for smoking cessation. Following the successful completion of two Phase 3 studies, the company submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA), which has been accepted for review. If approved, cytisinicline has the potential to become the first new FDA-approved treatment option for nicotine dependence in the United States in nearly two decades.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-08 17:01
4
English 7.2 KB
2025-11-14 21:05 English 9.6 KB
2025-11-14 11:54 English 9.7 KB
2025-11-06 08:15
10-Q
English 1.7 MB
2025-11-06 08:10
8-K
English 141.6 KB
2025-10-21 18:57
3
English 11.9 KB
2025-10-07 18:51
8-K
English 63.0 KB
2025-10-03 18:37
4
English 7.1 KB
2025-09-22 18:31
4
English 8.2 KB
2025-09-22 18:29
4
English 8.5 KB
2025-09-19 12:46
3
English 12.0 KB
2025-09-11 19:12
8-K
English 60.4 KB
2025-09-08 19:10
4
English 7.5 KB
2025-09-08 19:01
4
English 7.5 KB
2025-09-08 18:59
4
English 8.8 KB

Automate Your Workflow. Get a real-time feed of all ACHIEVE LIFE SCIENCES, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ACHIEVE LIFE SCIENCES, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ACHIEVE LIFE SCIENCES, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS
Acurx Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing a new class of antibiotics for priority pathogens.
United States of America
ACXP

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.